S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Michael Bogdan Scholarship Opens 2027 Applications for Students

Undergraduate students dedicated to patient care and medical innovation can now apply for the 2027 Michael Bogdan Scholarship for Healthcare. The program, established by the Boca Raton-based executive, seeks to identify future leaders who demonstrate academic excellence and a clear vision for advancing standards within the medical field.

Michael Bogdan Scholarship Opens 2027 Applications for Students
Photo: Bio & News

Founded by entrepreneur Michael Bogdan, the scholarship aims to alleviate the rising costs of higher education for those committed to clinical roles. Applicants must be currently enrolled at an accredited U.S. college or university, pursuing a degree that leads directly to a healthcare-related career. Selection is based on the strength of a submitted essay, academic performance, and evidence of a sustained commitment to patient outcomes.

"Healthcare continues to evolve through innovation, research, technology, and compassionate patient care," Bogdan stated, noting that the program is designed to support students who show potential to improve the communities they will eventually serve. Bogdan, who also manages medical office properties, established the fund to bridge the gap between academic potential and professional practice. Interested candidates have until April 15, 2027, to submit their applications, with the final recipient scheduled for announcement on May 15, 2027.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!